You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Determine whether one focused NeuralLiquid product is ready for The Baobab Network's Africa accelerator and submit only after product-company, MVP, traction and application-package gates pass.
Verified programme facts
The official application page accepts applications on a rolling basis and exposes a live application route.
Contradictory/stale public information: the same page still says the next cohort starts in Q4 2025, while the FAQ says several cohorts run each year. Current cohort timing must be confirmed before modelling a start date.
Geography: startup must be based in Africa and led/run by an African team; incorporation outside Africa is permitted if the company has an African presence.
Stage: preferably an MVP with early traction. Idea-stage teams need verifiable demand such as sign-ups, a customer waiting list or purchases.
Fit: for-profit, scalable tech or tech-enabled business with in-house ability to build. Agencies and custom-development businesses are generally excluded.
Investment: US$100,000 paid in one lump sum.
Standard terms: 12.5% equity.
Programme: remote, beginning with two weeks of intensive consulting followed by three months of hands-on venture support; no board seat and no programme fee.
Official sources verified: 2026-07-15.
Readiness
Blocked.
The main blockers are:
Select one scalable company/product story rather than a portfolio.
Confirm legal applicant, African operating presence, ownership, cap table and IP.
Prove NeuralLiquid is a product company, not an agency or custom-development consultancy.
Provide a working MVP and verified traction or explicit market-demand evidence.
Produce an English pitch deck and financial projections.
Provide team/domain expertise, revenue model, traction metrics, product roadmap, customer feedback, market size and competitor analysis.
Confirm acceptance of the standard US$100,000-for-12.5% deal.
Confirm the current cohort schedule directly because the public Q4 2025 date is stale.
Recommended fit gate
Apply only with the NeuralLiquid product that has the strongest current user-demand evidence and clearest scalable business model. A Cognitive Mesh-led application is stronger strategically; an OmniPost-led application may be more credible if its workflow and customer evidence are substantially more mature.
Application package
English pitch deck.
Financial projections and unit-economics assumptions.
MVP/demo URL or controlled recording.
Verifiable traction, waiting-list, pilot or revenue evidence.
Company, founder and African-presence evidence.
Product roadmap, customer feedback, market and competitor analysis.
Cap table, prior funding and acceptance of standard terms.
High-value and relevant, but dilutive. The stale cohort date is a public-information defect, not proof that the application route is closed. Do not submit until the product-company and evidence gates pass, and do not assume a cohort start date without direct confirmation.
Objective
Determine whether one focused NeuralLiquid product is ready for The Baobab Network's Africa accelerator and submit only after product-company, MVP, traction and application-package gates pass.
Verified programme facts
Readiness
Blocked.
The main blockers are:
Recommended fit gate
Apply only with the NeuralLiquid product that has the strongest current user-demand evidence and clearest scalable business model. A Cognitive Mesh-led application is stronger strategically; an OmniPost-led application may be more credible if its workflow and customer evidence are substantially more mature.
Application package
Official links
docs/plans/neuralliquid-funding-pipeline.mdFunding impact
High-value and relevant, but dilutive. The stale cohort date is a public-information defect, not proof that the application route is closed. Do not submit until the product-company and evidence gates pass, and do not assume a cohort start date without direct confirmation.